 |
 |
Thanks, Ray! Here's a link to a registration form for the MJFF webinar. There's space for registrants to submit questions in advance of the event. A big question for me is affordability of nilotinib. What good will it be if it's priced out of reach for most of us? I'd be curious to know what questions/comments others have. https://www.michaeljfox.org/understanding-parkinsons/webinar-registration.php?id=11&e=1224270&k=2CCA24B7E83A23999FBC4B1376C4F944 On Tuesday, July 12, 2016, Rayilyn Brown <[log in to unmask]> wrote: > we have to wait until 2017 > > > https://www.michaeljfox.org/foundation/news-detail.php?nilotinib-update-where-we-stand-with-cancer-drug-for-parkinson&et_cid=610090&et_rid=61638552&et_lid=Read+Moreem_cid= > > Ray > Rayilyn Brown > Past Director AZNPF > Arizona Chapter National Parkinson Foundation > > ---------------------------------------------------------------------- > To sign-off Parkinsn send a message to: mailto: > [log in to unmask] > In the body of the message put: signoff parkinsn > ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn